We are live on ! Find out more
Natixis Advisors

Natixis Advisors Portfolio holdings

AUM $71.9B
1-Year Est. Return 28.03%
This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
Cap. Flow
+$1.81B
Cap. Flow %
7.66%
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$31.5M
2
NTR icon
Nutrien
NTR
+$29.5M
3
T icon
AT&T
T
+$28.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$27.6M
5
SNY icon
Sanofi
SNY
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 18.61%
2 Healthcare 14.15%
3 Financials 13.71%
4 Consumer Discretionary 9.67%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGS icon
926
ONE Gas
OGS
$5.01B
$1.77M 0.01%
25,134
-414
-2% -$33.4K
GDDY icon
927
GoDaddy
GDDY
$13.9B
$1.77M 0.01%
24,926
+1,936
+8% +$146K
CLB icon
928
Core Laboratories
CLB
$455M
$1.76M 0.01%
130,433
-238
-0.2% -$4.01K
CPB icon
929
Campbell Soup
CPB
$6.85B
$1.75M 0.01%
37,246
+3,691
+11% +$181K
ITT icon
930
ITT
ITT
$17.1B
$1.75M 0.01%
26,863
+1,229
+5% +$89.6K
CYTK icon
931
Cytokinetics
CYTK
$10.6B
$1.75M 0.01%
36,205
+1,216
+3% +$58.5K
FIVE icon
932
Five Below
FIVE
$11.6B
$1.75M 0.01%
12,696
+2,116
+20% +$278K
ROL icon
933
Rollins
ROL
$18.6B
$1.75M 0.01%
50,418
+3,616
+8% +$130K
MOS icon
934
The Mosaic Company
MOS
$7.19B
$1.74M 0.01%
36,079
+7,664
+27% +$396K
GGB icon
935
Gerdau
GGB
$9.54B
$1.74M 0.01%
+485,343
New +$1.76M
CBT icon
936
Cabot Corp
CBT
$4.72B
$1.74M 0.01%
27,238
+10,492
+63% +$740K
ITOT icon
937
iShares Core S&P Total US Stock Market ETF
ITOT
$92.3B
$1.74M 0.01%
21,866
+1,749
+9% +$155K
LOPE icon
938
Grand Canyon Education
LOPE
$4.22B
$1.73M 0.01%
20,988
-54
-0.3% -$4.68K
XP icon
939
XP
XP
$8.43B
$1.72M 0.01%
90,364
-8,168
-8% -$162K
KRC icon
940
Kilroy Realty
KRC
$4.59B
$1.72M 0.01%
40,741
+6,162
+18% +$311K
NGVT icon
941
Ingevity
NGVT
$2.46B
$1.71M 0.01%
+28,134
New +$1.89M
KFY icon
942
Korn Ferry
KFY
$4.31B
$1.69M 0.01%
36,093
-2,436
-6% -$144K
HALO icon
943
Halozyme
HALO
$9.88B
$1.69M 0.01%
42,658
+4,818
+13% +$213K
NTST
944
NETSTREIT Corp
NTST
$2.13B
$1.69M 0.01%
94,734
+53,462
+130% +$1.07M
NFG icon
945
National Fuel Gas
NFG
$7.69B
$1.67M 0.01%
27,197
+5,513
+25% +$380K
BNS icon
946
Scotiabank
BNS
$105B
$1.67M 0.01%
35,076
-14,174
-29% -$810K
BCPC
947
Balchem Corp
BCPC
$5.26B
$1.67M 0.01%
13,698
+2,576
+23% +$336K
BNDX icon
948
Vanguard Total International Bond ETF
BNDX
$82B
$1.66M 0.01%
34,844
+545
+2% +$27.1K
JLL icon
949
Jones Lang LaSalle
JLL
$15.8B
$1.66M 0.01%
10,967
+34
+0.3% +$5.92K
UAL icon
950
United Airlines
UAL
$38.8B
$1.65M 0.01%
50,858
-31,310
-38% -$1.16M

Similar funds

Natixis Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $31.5M trimmed.

  • Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
  • Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
  • Natixis Advisors's biggest Q3 2022 reduction was Vanguard Total Stock Market ETF, cutting an estimated $31.5M.
  • Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
  • Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
  • Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
  • Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.

Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.